Study of CPI-200 in Patients With Advanced Tumors

Clinical trial NCT03953742 · COMPLETED

Trial details

NCT number: NCT03953742
Sponsor: Coordination Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2019-07-01
Primary completion: 2022-02-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.